Our recent mid-year sales review meeting brought together sales leaders and teams for a highly productive session. The meeting was crucial for: Enhancing Capabilities: A vital component of our recent mid-year sales review meeting was dedicated to enhancing our team’s capabilities through focused training sessions.

NEXT Pharma has taken a significant leap forward in combating counterfeit medicines and ensuring patient safety by integrating cutting-edge security features into its product packaging. This strategic move involves the adoption of sophisticated overt and covert technologies, prominently featuring fluorescent security seals, color-shifting seals, and specialized inks, all manufactured by the globally renowned security printing […]

NEXT Pharma recently hosted insightful awareness sessions focusing on Obeticholic Acid (OCA), a crucial medication used in the management of primary biliary cholangitis (PBC). These sessions aimed to educate healthcare professionals on the therapeutic benefits of OCA, its mechanism of action as a farnesoid X receptor (FXR) agonist, and its role in improving liver function […]

Mr. Shahmeer Khalid Butt, Managing Director Next Pharma and Mr. Rizwan Ahmed, MD IBL Operations signed the agreement. Mr. Azmat Khan, Associate Director IBL, Mr. Muhammad Siddique, Associate NSM IBL, Mr. Ameer Bukhari, Associate NSM IBL, Mr. Abid Rasool, Business Manager, Next Pharma and Mr. Javed Khan, Head of Marketing, Next Pharma were also present […]

NEXT Pharma is delighted to introduce Paranext, a trusted and essential solution for every household’s everyday health needs. Featuring the widely recognized and reliable active ingredient Paracetamol, Paranext offers effective relief from mild to moderate pain and fever, available in 500mg tablet formand child-friendly suspension formsof 120mg/5ml and 250mg/5ml. The launch of Paranext reaffirms NEXT […]

NEXT Pharma is proud to announce the launch of Obetinext (Obeticholic Acid), a pioneering therapeutic agent poised to redefine the management of chronic liver diseases, particularly Primary Biliary Cholangitis (PBC), and contribute to broader metabolic health. NEXT Pharma is committed to ensuring healthcare providers have comprehensive support and information for optimal patient management, including monitoring […]

NEXT Pharma is proud to introduce Dapanext (Dapagliflozin) and Dapanext M (Dapagliflozin + Metformin), two innovative medications set to transform the landscape of Type 2 Diabetes management. These new offerings underscore our dedication to providing advanced therapeutic solutions that go beyond simple blood sugar control, addressing the broader health needs of patients. This launch signifies […]

NEXT Pharma is proud to unveil Linzanext (Linezolid), a groundbreaking addition to our arsenal against severe bacterial infections. Featuring the potent active ingredient Linezolid, Linzanext stands as a crucial therapeutic advancement, particularly in an era where multi-drug-resistant Gram-positive bacteria pose significant challenges to patient care. The introduction of Linzanext underscores NEXT Pharma’s unwavering commitment to […]

NEXT Pharma recently concluded its highly successful Annual Sales Conference in the scenic hill station of Murree. The conference brought together sales teams from across the region for a series of insightful sessions, strategic planning, and team-building activities. Key highlights of the conference included: The conference served as a crucial platform for aligning the sales […]